During the past decade, Allergy, Asthma and Immunology Center, PC conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Allergy, Asthma and Immunology Center, PC" are "Crohn Disease" (3 trials), "Chronic Rhinosinusitis" (1 trials) and "Primary Immunodeficiency" (1 trials). Many other conditions were trialed in "Allergy, Asthma and Immunology Center, PC" in a lesser frequency.

Most popular intervention types in "Allergy, Asthma and Immunology Center, PC" are "Drug" (4 trials), "Biological" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Ozanimod" (3 trials), "Placebo" (3 trials), "Etokimab" (1 trials), "Gamunex-C" (1 trials) and "IVIG-PEG" (1 trials). Other intervention names were less common.

The vast majority of trials in "Allergy, Asthma and Immunology Center, PC" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Allergy, Asthma and Immunology Center, PC". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Allergy, Asthma and Immunology Center, PC, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Allergy, Asthma and Immunology Center, PC, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".